|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
|
|
2
|
Xiong X, Zheng LW, Ding Y, Chen YF, Cai
YW, Wang LP, Huang L, Liu CC, Shao ZM and Yu KD: Breast cancer:
Pathogenesis and treatments. Signal Transduct Target Ther.
10:492025. View Article : Google Scholar :
|
|
3
|
Obidiro O, Battogtokh G and Akala EO:
Triple negative breast cancer treatment options and limitations:
Future outlook. Pharmaceutics. 15:17962023. View Article : Google Scholar :
|
|
4
|
Milane LS, Dolare S, Ren G and Amiji M:
Combination organelle mitochondrial endoplasmic reticulum therapy
(COMET) for multidrug resistant breast cancer. J Control Release.
363:435–451. 2023. View Article : Google Scholar
|
|
5
|
Liu J, Liu Y, Wang Y, Li C, Xie Y,
Klionsky DJ, Kang R and Tang D: TMEM164 is a new determinant of
autophagy-dependent ferroptosis. Autophagy. 19:945–956. 2023.
View Article : Google Scholar
|
|
6
|
Tanida I: Autophagosome formation and
molecular mechanism of autophagy. Antioxid Redox Signal.
14:2201–2214. 2011. View Article : Google Scholar
|
|
7
|
Quan Y, Lei H, Wahafu W, Liu Y, Ping H and
Zhang X: Inhibition of autophagy enhances the anticancer effect of
enzalutamide on bladder cancer. Biomed Pharmacother.
120:1094902019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cocco S, Leone A, Piezzo M, Caputo R, Di
Lauro V, Di Rella F, Fusco G, Capozzi M, Gioia GD, Budillon A and
De Laurentiis M: Targeting autophagy in breast cancer. Int J Mol
Sci. 21:78362020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Jiang L, Yu L, Li Q, Tian X, He
J, Zeng L, Yang Y, Wang C, Wei Y, et al: Inhibition of UBA6 by
inosine augments tumour immunogenicity and responses. Nat Commun.
13:54132022. View Article : Google Scholar
|
|
10
|
Zhao H, Yang M, Zhao J, Wang J, Zhang Y
and Zhang Q: High expression of LC3B is associated with progression
and poor outcome in triple-negative breast cancer. Med Oncol.
30:4752013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu S, Cao Z, Cai F, Yao Y, Chang X, Wang
X, Zhuang H and Hua ZC: ADT-OH exhibits anti-metastatic activity on
triple-negative breast cancer by combinatorial targeting of
autophagy and mitochondrial fission. Cell Death Dis. 15:4632024.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hamurcu Z, Delibaşı N, Geçene S, Şener EF,
Dönmez-Altuntaş H, Özkul Y, Canatan H and Ozpolat B: Targeting LC3
and Beclin-1 autophagy genes suppresses proliferation, survival,
migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin
β1/Src signaling in triple negative breast cancer cells. J Cancer
Res Clin Oncol. 144:415–430. 2018. View Article : Google Scholar
|
|
13
|
Spinelli FR, Moscarelli E, Ceccarelli F,
Miranda F, Perricone C, Truglia S, Garufi C, Massaro L, Morello F,
Alessandri C, et al: Treating lupus patients with antimalarials:
Analysis of safety profile in a single-center cohort. Lupus.
27:1616–1623. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zheng Z, Liu J, Ma J, Kang R, Liu Z and Yu
J: Advances in new targets for immunotherapy of small cell lung
cancer. Thorac Cancer. 15:3–14. 2024. View Article : Google Scholar :
|
|
15
|
Herrera-Quintana L, Vázquez-Lorente H and
Plaza-Diaz J: Breast cancer: Extracellular matrix and microbiome
interactions. Int J Mol Sci. 25:72262024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Duan Z, Shi Y, Lin Q, Hamaï A, Mehrpour M
and Gong C: Autophagy-associated immunogenic modulation and its
applications in cancer therapy. Cells. 11:23242022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Galluzzi L, Buqué A, Kepp O, Zitvogel L
and Kroemer G: Immunological effects of conventional chemotherapy
and targeted anticancer agents. Cancer Cell. 28:690–714. 2015.
View Article : Google Scholar
|
|
18
|
Xu X, Araki K, Li S, Han JH, Ye L, Tan WG,
Konieczny BT, Bruinsma MW, Martinez J, Pearce EL, et al: Autophagy
is essential for effector CD8(+) T cell survival and memory
formation. Nat Immunol. 15:1152–1161. 2014. View Article : Google Scholar :
|
|
19
|
Liu YC, Shou ST and Chai YF: Immune
checkpoints in sepsis: New hopes and challenges. Int Rev Immunol.
41:207–216. 2022. View Article : Google Scholar
|
|
20
|
Thomenius MJ, Totman J, Harvey D, Mitchell
LH, Riera TV, Cosmopoulos K, Grassian AR, Klaus C, Foley M,
Admirand EA, et al: Small molecule inhibitors and CRISPR/Cas9
mutagenesis demonstrate that SMYD2 and SMYD3 activity are
dispensable for autonomous cancer cell proliferation. PLoS One.
13:e01973722018. View Article : Google Scholar :
|
|
21
|
Eggert E, Hillig RC, Koehr S, Stöckigt D,
Weiske J, Barak N, Mowat J, Brumby T, Christ CD, Ter Laak A, et al:
Discovery and characterization of a highly potent and selective
aminopyrazoline-based in vivo probe (BAY-598) for the protein
lysine methyltransferase SMYD2. J Med Chem. 59:4578–4600. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sweis RF, Wang Z, Algire M, Arrowsmith CH,
Brown PJ, Chiang GG, Guo J, Jakob CG, Kennedy S, Li F, et al:
Discovery of A-893, a new cell-active benzoxazinone inhibitor of
lysine methyltransferase SMYD2. ACS Med Chemi Lett. 6:695–700.
2015. View Article : Google Scholar
|
|
23
|
Zhang B, Liao L, Wu F, Zhang F, Sun Z,
Chen H and Luo C: Synthesis and structure-activity relationship
studies of LLY-507 analogues as SMYD2 inhibitors. Bioorg Med Chem
Lett. 30:1275982020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tam S, Al-Zubaidi Y, Rahman MK, Bourget K,
Zhou F and Murray M: The ixabepilone and vandetanib combination
shows synergistic activity in docetaxel-resistant MDA-MB-231 breast
cancer cells. Pharmacol Rep. 74:998–1010. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang K, Zhu X and Yin Y: Maslinic acid
enhances docetaxel response in human docetaxel-resistant triple
negative breast carcinoma MDA-MB-231 cells via regulating
MELK-FoxM1-ABCB1 signaling cascade. Front Pharmacol. 11:8352020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taherian A and Mazoochi T: Different
expression of extracellular signal-regulated kinases (ERK) 1/2 and
Phospho-Erk Proteins in MBA-MB-231 and MCF-7 cells after
chemotherapy with doxorubicin or docetaxel. Iran J Basic Med Sci.
15:669–677. 2012.PubMed/NCBI
|
|
27
|
Jones S, Holmes FA, O'Shaughnessy J, Blum
JL, Vukelja SJ, McIntyre KJ, Pippen JE, Bordelon JH, Kirby RL,
Sandbach J, et al: Docetaxel with cyclophosphamide is associated
with an overall survival benefit compared with doxorubicin and
cyclophosphamide: 7-year follow-up of US oncology research trial
9735. J Clin Oncol. 27:1177–1183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Capri G, Tarenzi E, Fulfaro F and Gianni
L: The role of taxanes in the treatment of breast cancer. Semin
Oncol. 23(Suppl 2): S68–S75. 1996.
|
|
29
|
McLeland CB, Rodriguez J and Stern ST:
Autophagy monitoring assay: Qualitative analysis of MAP LC3-I to II
conversion by immunoblot. Methods Mol Biol. 697:199–206. 2011.
View Article : Google Scholar
|
|
30
|
Colosetti P, Puissant A, Robert G, Luciano
F, Jacquel A, Gounon P, Cassuto JP and Auberger P: Autophagy is an
important event for megakaryocytic differentiation of the chronic
myelogenous leukemia K562 cell line. Autophagy. 5:1092–1098. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr
M, Hijlkema KJ, Coppes RP, Engedal N, Mari M and Reggiori F:
Chloroquine inhibits autophagic flux by decreasing
autophagosome-lysosome fusion. Autophagy. 14:1435–1455. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu Z, Han X, Ou D, Liu T, Li Z, Jiang G,
Liu J and Zhang J: Targeting PI3K/AKT/mTOR-mediated autophagy for
tumor therapy. Appl Microbiol Biotechnol. 104:575–587. 2020.
View Article : Google Scholar
|
|
33
|
Cui Y, Shi J, Cui Y, Zhu Z and Zhu W: The
relationship between autophagy and PD-L1 and their role in
antitumor therapy. Front Immunol. 14:10935582023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kroczek R and Hamelmann E: T-cell
costimulatory molecules: Optimal targets for the treatment of
allergic airway disease with monoclonal antibodies. J Allergy Clin
Immunol. 116:906–909. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roy D, Gilmour C, Patnaik S and Wang LL:
Combinatorial blockade for cancer immunotherapy: Targeting emerging
immune checkpoint receptors. Front Immunol. 14:12643272023.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang L, Qiang P, Yu J, Miao Y, Chen Z, Qu
J, Zhao Q, Chen Z, Liu Y, Yao X, et al: Identification of compound
CA-5f as a novel late-stage autophagy inhibitor with potent
anti-tumor effect against non-small cell lung cancer. Autophagy.
15:391–406. 2019. View Article : Google Scholar :
|
|
37
|
Wu ST, Han SS, Xu XM, Sun HJ, Zhou H,
Shang K, Liu ZH and Liang SJ: 3-methyladenine ameliorates
surgery-induced anxiety-like behaviors in aged mice by inhibiting
autophagy-induced excessive oxidative stress. Metab Brain Dis.
38:1913–1923. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shih FC, Lin CF, Wu YC, Hsu CC, Chen BC,
Chang YC, Lin YS, Satria RD, Lin PY and Chen CL:
Desmethylclomipramine triggers mitochondrial damage and death in
TGF-β-induced mesenchymal type of A549 cells. Life Sci.
351:1228172024. View Article : Google Scholar
|
|
39
|
Dong X, Zhao R, Li Y, Yu Q, Chen X, Hu X,
Ma J, Chen X, Huang S and Chen L: Maduramicin inactivation of Akt
impairs autophagic flux leading to accumulated
autophagosomes-dependent apoptosis in skeletal myoblast cells. Int
J Biochem Cell Biol. 114:1055732019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pan SW, Hu LS, Wang H, Li RT, He YJ, Shang
Y, Dai ZL, Chen LX and Xiong W: Resolvin D1 induces
mTOR-independent and ATG5-dependent autophagy in BV-2 microglial
cells. Curr Med Sci. 43:1096–1106. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jain V, Singh MP and Amaravadi RK: Recent
advances in targeting autophagy in cancer. Trends Pharmacol Sci.
44:290–302. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu Q, Yang Y, Cheng M, Cheng F, Chen S,
Zheng Q, Sun Y and Chen L: The marine natural product, dicitrinone
B, induces apoptosis through autophagy blockade in breast cancer.
Int J Mol Med. 50:1302022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Young TM, Reyes C, Pasnikowski E,
Castanaro C, Wong C, Decker CE, Chiu J, Song H, Wei Y, Bai Y, et
al: Autophagy protects tumors from T cell-mediated cytotoxicity via
inhibition of TNFα-induced apoptosis. Sci Immunol. 5:eabb95612020.
View Article : Google Scholar
|
|
44
|
Prabakaran T, Bodda C, Krapp C, Zhang BC,
Christensen MH, Sun C, Reinert L, Cai Y, Jensen SB, Skouboe MK, et
al: Attenuation of cGAS-STING signaling is mediated by a
p62/SQSTM1-dependent autophagy pathway activated by TBK1. EMBO J.
37:e978582018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang HJ, Liang CL, Ding XY, Zhang M, Lu
SY and Hou L: Manganese-based nano-delivery system for sensitized
anti-tumor immunotherapy via combined autophagy inhibition. Chinese
Chem Lett. 36:1105252025. View Article : Google Scholar
|
|
46
|
Herhaus L, Gestal-Mato U, Eapen VV,
Mačinković I, Bailey HJ, Prieto-Garcia C, Misra M, Jacomin AC,
Ammanath AV, Bagarić I, et al: IRGQ-mediated autophagy in MHC class
I quality control promotes tumor immune evasion. Cell.
187:7285–7302.e29. 2024. View Article : Google Scholar : PubMed/NCBI
|
